We and other authors have detected low-grade systemic inflammation, alterations indicative of endothelial dysfunction, and altered adipokine levels alongside the disorders that define MetS (4–6) as well as an increase in leptin and decrease in adiponectin in children with obesity. This evidence concerns the gene ADIPOQ and metabolic syndrome.